Treatment of tumors resected from tumor-implanted hu-BLT mice infused with sNK and treated with IL-2 substantially increased the levels of MHC class I expression when compared to mice implanted with tumors alone (Figure 4D). The gene discussed is IL2; the disease is neoplasm.